Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 82804-095

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 82804-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

82804-095-30 (Oxy Chl Ex Rel Tab Usp 10mg 100 Ct Label)

82804-095-30 (Oxy Chl Ex Rel Tab Usp 10mg 100 Ct Label)
Label for Oxybutynin Chloride 10 mg extended release tablets by Proficient Rx LP. The label shows a count of 30 tablets, specifying each contains 10 mg Oxybutynin Chloride USP in a controlled-release formulation. Tablets are described as pink, round, biconvex with an orifice, imprinted with 'P' over '10' in black ink. Manufacturer is Unique Pharmaceutical Laboratories, Mumbai, India. Includes NDC 82804-095-30 and barcode.*
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours for oxybutynin chloride extended-release tablets 10 mg once daily (QD) versus oxybutynin 5 mg three times daily (TID). Concentration values are plotted on the y-axis and time in hours on the x-axis, with error bars showing variability.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph showing the mean R-Oxybutynin plasma concentration (ng/mL) over time (hours) from 0 to 24. Data points are plotted with error bars representing variability, displaying an initial increase in concentration around 5 hours followed by a gradual decline up to 24 hours.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A horizontal error bar chart comparing Oxybutynin Chloride Extended-Release Tablets and Placebo. The chart shows data points with error bars around values approximately -20 for Oxybutynin Chloride and slightly less than 0 for Placebo, indicating differences with statistical significance marked for Oxybutynin Chloride.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A horizontal bar chart comparing two items: 'Oxybutynin chloride extended-release tablets' and 'oxybutynin'. The chart shows a variable on the x-axis ranging approximately from -40 to 40, with bars extending left of zero, indicating negative values for both items.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40, showing data points for both forms with associated error bars.*
FDA Label Image
Rising-logo (Rising Logo)
FDA Label Image

Structure (Structural Formula)

Structure (Structural Formula)
Chemical structure of oxybutynin chloride, showing its molecular formula including ester, aromatic, alkyne, and hydrochloride functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.